GNAQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.921400E-01
Normal-vs-Stage2
7.038400E-01
Normal-vs-Stage3
4.400600E-01
Normal-vs-Stage4
2.351800E-01
Stage1-vs-Stage2
5.622800E-01
Stage1-vs-Stage3
8.389800E-02
Stage1-vs-Stage4
2.557600E-01
Stage2-vs-Stage3
1.495790E-01
Stage2-vs-Stage4
2.931900E-02
Stage3-vs-Stage4
5.726100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.444400E-01
Normal-vs-AfricanAmerican
6.108200E-01
Normal-vs-Asian
7.375200E-01
Caucasian-vs-AfricanAmerican
4.252200E-01
Caucasian-vs-Asian
8.422800E-01
AfricanAmerican-vs-Asian
6.791400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.946600E-01
Normal-vs-Female
7.286000E-01
Male-vs-Female
8.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.497800E-01
Normal-vs-Age(41-60Yrs)
4.265200E-01
Normal-vs-Age(61-80Yrs)
8.514600E-01
Normal-vs-Age(81-100Yrs)
8.788400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.825800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.879400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.424600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.524380E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.654000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.195400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.664800E-01
Normal-vs-Daily Drinker
9.128400E-01
Normal-vs-Weekly Drinker
9.779600E-01
Normal-vs-Occasional Drinker
6.250800E-01
Normal-vs-Social Drinker
4.496600E-01
Non Drinker-vs-Daily Drinker
8.522600E-01
Non Drinker-vs-Weekly Drinker
8.923200E-01
Non Drinker-vs-Occasional Drinker
2.128400E-01
Non Drinker-vs-Social Drinker
8.329800E-02
Daily Drinker-vs-Weekly Drinker
8.031400E-01
Daily Drinker-vs-Occasional Drinker
2.398000E-01
Daily Drinker-vs-Social Drinker
1.178980E-01
Weekly Drinker-vs-Occasional Drinker
4.083400E-01
Weekly Drinker-vs-Social Drinker
2.252000E-01
Occasional Drinker-vs-Social Drinker
7.008400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.035600E-02
Normal-vs-Grade 2
1.107880E-02
Normal-vs-Grade 3
1.509950E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.905950E-01
Grade 1-vs-Grade 3
4.757800E-01
Grade 1-vs-Grade 4
8.035600E-02
Grade 2-vs-Grade 3
5.243600E-01
Grade 2-vs-Grade 4
1.107880E-02
Grade 3-vs-Grade 4
1.509950E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.869400E-01
Normal-vs-NonDiabetic
7.704600E-01
Diabetic-vs-NonDiabetic
3.352000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.655000E-01
Normal-vs-NoPancreatitis
7.902800E-01
Pancreatitis-vs-NoPancreatitis
8.114200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.888600E-01
Normal-vs-N1
7.043800E-01
N0-vs-N1
8.342400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.723400E-01
Normal-vs-TP53-NonMutant
6.940400E-01
TP53-Mutant-vs-TP53-NonMutant
5.964800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
